MIM
BDSI

MetLife Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

MetLife Investment Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,018
Closed -$15.6K – 2814
2021
Q4 		$15.6K Sell
5,018
-29,561
-85% -$99.5K ﹤0.01% 2489
2021
Q3 		$125K Buy
34,579
+26,128
+309% +$98.6K ﹤0.01% 2343
2021
Q2 		$30.3K Sell
8,451
-32,102
-79% -$113K ﹤0.01% 2432
2021
Q1 		$159K Buy
40,553
+21,720
+115% +$89.7K ﹤0.01% 2168
2020
Q4 		$79.1K Buy
18,833
+1,008
+6% +$3.88K ﹤0.01% 2241
2020
Q3 		$66.5K Sell
17,825
-21,764
-55% -$92.6K ﹤0.01% 2258
2020
Q2 		$173K Hold
39,589
– – ﹤0.01% 1989
2020
Q1 		$150K Buy
39,589
+13,163
+50% +$64.7K ﹤0.01% 1851
2019
Q4 		$167K Sell
26,426
-15,105
-36% -$88.8K ﹤0.01% 2079
2019
Q3 		$175K Hold
41,531
– – ﹤0.01% 2014
2019
Q2 		$193K Buy
+41,531
New +$193K ﹤0.01% 2045

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

MetLife Investment Management's BDSI Position: Q1 2022 in Review

MetLife Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 5,018 shares — an estimated $15.6K sold.

MetLife Investment Management first reported a position in BDSI in Q2 2019 and held it in 11 quarters. The position peaked at $193K in Q2 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • MetLife Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • MetLife Investment Management sold 5,018 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $15.6K.
  • MetLife Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 11 quarters.
  • MetLife Investment Management's BioDelivery Sciences International, Inc. position peaked at $193K in Q2 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.